Darunavir
NDC 31722-088, Darunavir, tablet, film coated, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-088
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216168
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DARUNAVIR600 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-088-60 | 31722008860 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-088-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/49606d5e-f45f-45eb-9ab8-15aa6a233875
Use it
Look up 31722-088 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-088. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.